# US 2026/0248660 A1 · Ostomy output indicator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0248660 A1
- Document ID: US20260248660A1
- Status: Published application
- Kind: A1
- Application number: 19/161,870
- Filed: 2024-03-15
- Published: 2026-08-27
- Earliest claimed: 2023-03-15
- Assignees: Hollister Incorporated
- Applicants: Hollister Incorporated
- Inventors: Julie Gawenda; Jennifer Meza; Rene Sieracki; Mary Ashley Tenedor; Waeezah Waqar; Abram Janis
- Web page: https://patentgrep.com/patent/US20260248660A1

## CPC

- A61F 13/42: with wetness indicator or alarm
- G01N 33/50: Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q)
- A61F 5/455: for collecting urine or discharge from female member
- C12Q 1/37: involving peptidase or proteinase
- A61F 2013/422: {the alarm being a colour change}
- A61F 2013/8473: {for diagnostic purposes}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A device for quantifying dejecta enzymes includes a plurality of layers, each layer including a hydrophobic material and a paper or paper-based material, the hydrophobic material being sealed to the paper or paper-based material. One of the plurality of layers is a first layer. The other layers define an assay column and a control column, the columns being isolated from one another by the hydrophobic material. In the assay column, the paper or paper-based material in a second layer includes an inhibitor or a dye or no inhibitor or dye. The paper or paper-based material in a third layer includes a colorimetric substrate, and the paper or paper-based material in a fourth layer includes no inhibitor or dye or colorimetric substrate. In the control column, the paper or paper-based material in the second layer includes no inhibitor or dye or colorimetric substrate, the paper or paper-based material in the third layer includes a dye, and the paper or paper-based material in a fourth layer includes no inhibitor or dye or colorimetric substrate. A method for quantifying dejecta enzymes is also disclosed.

## Claims

### Claim 1

A device for quantifying dejecta enzymes comprising:
a plurality of layers, each layer including a hydrophobic material and a paper or paper-based material, the hydrophobic material being sealed to paper or paper-based material,
one of the plurality of layers being a first layer, the other of the plurality of layers defining an assay column and a control column, the assay column and the control column being isolated from one another by the hydrophobic material,
wherein in the assay column, the paper or paper-based material in a first of the other of the plurality of layers includes an inhibitor or a dye or no inhibitor or dye, the paper or paper-based material in a second of the other of the plurality of layers includes a colorimetric substrate, and the paper or paper-based material in a third of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate, and
wherein in the control column, the paper or paper-based material in a first of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate, the paper or paper-based material in a second of the other of the plurality of layers includes a dye, and the paper or paper-based material in a third of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate.

### Claim 2 (depends on 1)

The device of claim 1, wherein the hydrophobic material is wax.

### Claim 3 (depends on 2)

The device of claim 2, wherein the assay column and the control column are formed by openings in the wax in the others of the plurality of layers.

### Claim 4 (depends on 3)

The device of claim 3, wherein the first layer is a buffer layer, the buffer layer includes an opening.

### Claim 5 (depends on 3)

The device of claim 3, wherein the openings in the wax in the assay column are aligned with one another and the openings in the wax in the control column are aligned from one another, wherein the assay column and the control column are spaced from one another.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The device of claim 1, wherein in the assay column, the paper or paper-based material in the first of the other of the plurality of layers includes an inhibitor and/or a dye.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The device of claim 1, wherein in the assay column, the paper or paper-based material in the first of the other of the plurality of layers includes no inhibitor or dye.

### Claim 10 (depends on 1)

The device of claim 1, wherein the paper or paper-based material is a chromatography paper.

### Claim 11 (depends on 1)

The device of claim 1, wherein each layer of the plurality of layers is adhered to each adjacent layer.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The device of claim 1, wherein the device is configured to detect the concentration of chymotrypsin in a sample of ostomy output or dejecta.

### Claim 14 (depends on 13)

The device of claim 13, wherein the inhibitor is a protease inhibitor.

### Claim 15 (depends on 1)

The device of claim 1, wherein the inhibitor is one or more of 1-chloro-3-tosylamido-7-amino-2-heptanone (TLCK), L-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK), elastase inhibitor I or 2, and combinations thereof.

### Claim 16 (depends on 1)

The device of claim 1, wherein the colorimetric substrate is a chymotrypsin colorimetric substrate defined by Suc-Gly-Gly-Phe-pNA.

### Claim 17 (depends on 1)

The device of claim 1, wherein in the assay column, the dye is a blue dye, and the dye is a green dye in the control column.

### Claim 18

(canceled)

### Claim 19

A method of quantifying dejecta enzymes comprising:
introducing a sample of dejecta into a device having a plurality of layers, each layer including a hydrophobic material and a paper or paper-based material, the hydrophobic material being sealed to paper or paper-based material, one of the plurality of layers being a first layer, the other of the plurality of layers defining an assay column and a control column, the assay column and the control column being isolated from one another by the hydrophobic material,
wherein in the assay column, the paper or paper-based material in a first of the other of the plurality of layers includes an inhibitor or a dye or no inhibitor or dye, the paper or paper-based material in a second of the other of the plurality of layers includes a colorimetric substrate, and the paper or paper-based material in a third of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate, and
wherein in the control column, the paper or paper-based material in a first of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate, the paper or paper-based material in a second of the other of the plurality of layers includes a dye, and the paper or paper-based material in a third of the other of the plurality of layers includes no inhibitor or dye or colorimetric substrate; and
comparing a color of the dejecta migrating through the device and appearing in the paper or paper-based material in the third of the other of the plurality of layers with a known color key.

### Claim 20 (depends on 19)

The method of claim 19, wherein the device is configured to detect the concentration of chymotrypsin in a sample of ostomy output or dejecta.

### Claim 21 (depends on 19)

The method of claim 19, wherein the inhibitor is a protease inhibitor.

### Claim 22 (depends on 19)

The method of claim 19, wherein the inhibitor is one or more of 1-chloro-3-tosylamido-7-amino-2-heptanone (TLCK), L-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK), elastase inhibitor I or 2, and combinations thereof.

### Claim 23 (depends on 19)

The method of claim 19, wherein the colorimetric substrate is a chymotrypsin colorimetric substrate defined by Suc-Gly-Gly-Phe-pNA.

### Claim 24 (depends on 19)

The method of claim 19, wherein in the assay column, the dye is a blue dye, and the dye is a green dye in the control column.

### Claim 25

(canceled)
